SARS-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care.

Details

Ressource 1Download: 32453451_BIB_BA01F2C7D1AF.pdf (2069.83 [Ko])
State: Public
Version: Author's accepted manuscript
License: All rights reserved
Serval ID
serval:BIB_BA01F2C7D1AF
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
SARS-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care.
Journal
Prenatal diagnosis
Author(s)
Lambelet V., Vouga M., Pomar L., Favre G., Gerbier E., Panchaud A., Baud D.
ISSN
1097-0223 (Electronic)
ISSN-L
0197-3851
Publication state
Published
Issued date
12/2020
Peer-reviewed
Oui
Volume
40
Number
13
Pages
1641-1654
Language
english
Notes
Publication types: Comparative Study ; Journal Article ; Review
Publication Status: ppublish
Abstract
Since December 2019, the novel SARS-CoV-2 outbreak has resulted in millions of cases and more than 200 000 deaths worldwide. The clinical course among nonpregnant women has been described, but data about potential risks for women and their fetus remain scarce. The SARS and MERS epidemics were responsible for miscarriages, adverse fetal and neonatal outcomes, and maternal deaths. For COVID-19 infection, only nine cases of maternal death have been reported as of 22 April 2020, and pregnant women seem to develop the same clinical presentation as the general population. However, severe maternal cases, as well as prematurity, fetal distress, and stillbirth among newborns have been reported. The SARS-CoV-2 pandemic greatly impacts prenatal management and surveillance and raise the need for clear unanimous guidelines. In this narrative review, we describe the current knowledge about coronaviruses (SARS, MERS, and SARS-CoV-2) risks and consequences on pregnancies, and we summarize available current candidate therapeutic options for pregnant women. Finally, we compare current guidance proposed by The Royal College of Obstetricians and Gynaecologists, The American College of Obstetricians and Gynecologists, and the World Health Organization to give an overview of prenatal management which should be utilized until future data appear.
Keywords
COVID-19/drug therapy, Communicable Diseases, Emerging, Coronavirus Infections/epidemiology, Coronavirus Infections/therapy, Coronavirus Infections/virology, Female, Humans, Pandemics, Practice Guidelines as Topic, Pregnancy, Pregnancy Complications, Infectious/epidemiology, Pregnancy Complications, Infectious/therapy, Pregnancy Complications, Infectious/virology, Prenatal Care, SARS-CoV-2
Pubmed
Web of science
Open Access
Yes
Create date
10/06/2020 21:27
Last modification date
04/11/2023 7:07
Usage data